Interleukin-10 reduces circulating levels of serum cytokines in experimental pancreatitis
- 1 March 1997
- journal article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 1 (2), 159-166
- https://doi.org/10.1016/s1091-255x(97)80104-7
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Anti-TNFα therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the ratThe American Journal of Surgery, 1996
- Interleukin 10 prevents necrosis in murine experimental acute pancreatitisGastroenterology, 1995
- Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitisSurgery, 1995
- Decreased Mortality of Severe Acute Pancreatitis After Proximal Cytokine BlockadeAnnals of Surgery, 1995
- Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-α polyclonal antibodyThe American Journal of Surgery, 1994
- Interleukin-10Annual Review of Immunology, 1993
- Interleukin 10 protects mice from lethal endotoxemia.The Journal of Experimental Medicine, 1993
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.The Journal of Experimental Medicine, 1991
- Interleukin 1: the first interleukinImmunology Today, 1990
- Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.The Journal of Experimental Medicine, 1989